Insulet (PODD) Operating Expenses (2010 - 2026)
Insulet's (PODD) quarterly Operating Expenses came in at $406.9 million in Q1 2026, up 27.04% YoY from $320.3 million in Q1 2025, and down 3.65% on a QoQ basis from $422.3 million in Q4 2025.
Insulet (PODD) Operating Expenses (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Operating Expenses data on file, last reported at $406.9 million in Q1 2026.
- Quarterly Operating Expenses rose 27.04% year-over-year to $406.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 28.62% YoY) and the FY2025 annual result came in at $1.5 billion, up 28.97% from the prior year.
- Operating Expenses declined to $406.9 million in Q1 2026, from $422.3 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $422.3 million in Q4 2025 to a low of $171.8 million in Q1 2022.
- A 5-year average of $277.5 million and a median of $254.7 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 441.15% — and 2023, when it grew 7.74%.
- Tracing PODD's Operating Expenses over 5 years: stood at $193.8 million in 2022, then surged by 31.42% to $254.7 million in 2023, then grew by 26.23% to $321.5 million in 2024, then surged by 31.35% to $422.3 million in 2025, then slipped by 3.65% to $406.9 million in 2026.
- The last three Operating Expenses figures came in at $406.9 million (Q1 2026), $422.3 million (Q4 2025), and $392.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Insulet | 10.18 Bn | 9.64 Bn | 562.60 Mn | 432.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 432.90 Mn |
| Mar 31, 2026 | 406.90 Mn |
| Dec 31, 2025 | 422.30 Mn |
| Sep 30, 2025 | 392.40 Mn |
| Jun 30, 2025 | 331.10 Mn |
| Mar 31, 2025 | 320.30 Mn |
| Dec 31, 2024 | 321.50 Mn |
| Sep 30, 2024 | 289.00 Mn |
| Jun 30, 2024 | 276.40 Mn |
| Mar 31, 2024 | 249.90 Mn |
| Dec 31, 2023 | 254.70 Mn |
| Sep 30, 2023 | 238.50 Mn |
| Jun 30, 2023 | 233.80 Mn |
| Mar 31, 2023 | 212.80 Mn |
| Dec 31, 2022 | 193.80 Mn |
| Sep 30, 2022 | 185.40 Mn |
| Jun 30, 2022 | 217.00 Mn |
| Mar 31, 2022 | 171.80 Mn |
| Dec 31, 2021 | 41.80 Mn |
| Sep 30, 2021 | 117.50 Mn |